Journal
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
Volume 46, Issue 1, Pages 1-7Publisher
ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.jgyn.2016.01.002
Keywords
Dehydroepiandrosterone (DHEA); Diminished ovarian reserve (DOR); Poor ovarian response (POR); In vitro fertilization (IVF)
Categories
Ask authors/readers for more resources
To evaluate the effect of dehydroepiandrosterone (DHEA) therapy on the ovarian response and pregnancy outcome in patients with diminished ovarian reserve (DOR). Eligible studies, published before August 31, 2015, were identified from PubMed, EMBASE, the Cochrane library. Outcome measures were the number of retrieved oocytes, cancellation rate of IVF cycles, clinical pregnancy rate and miscarriage rate. We adopted Revman 5.0 software to pool the data from the eligible studies. A total of 9 studies, four were RCTs, four retrospective studies, one prospective studies, including 540 cases and 668 controls, were available for analysis. The pooled analysis showed that the clinical pregnancy rates were increased significantly in DOR patients who were pre-treated with DHEA (OR = 1.47, 95% CI: 1.09-1.99), whereas no differences were found in the number of oocytes retrieved, the cancellation rate of IVF cycles and the miscarriage rate between the cases and controls (WMD= -0.69, 95% CI: -2.18-0.81; OR = 0.74, 95% CI: 0.51-1.08; OR= 0.34, 95% CI: 0.10-1.24). However; it is worth noting that when data were restricted to RCTs, there was a non-significant difference in the clinical pregnancy rate (OR = 1.08, 95% CI: 0.67-1.73). We concluded that DHEA supplementation in DOR patients might improve the pregnancy outcomes. To further confirm this effect, more randomized controlled trials with large sample sizes are needed. (C) 2016 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available